The pharma microbiology testing kits market size has grown strongly in recent years. It will grow from $7.26 billion in 2025 to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to pharmaceutical quality regulations, biologics production growth, contamination risk awareness, vaccine manufacturing expansion, gmp compliance requirements.
The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $11.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to biopharmaceutical pipeline growth, rapid testing technology adoption, regulatory stringency increase, contract manufacturing expansion, automation in quality control. Major trends in the forecast period include increased sterility testing frequency, rising adoption of rapid microbial detection, expansion of environmental monitoring programs, higher demand for ready-to-use test kits, outsourcing of microbiology testing services.
The growing prevalence of infectious diseases is increasingly supporting the expansion of the pharma microbiology testing kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, which can spread directly or indirectly between individuals. The incidence of infectious diseases continues to rise due to increased global travel, which accelerates the cross-border transmission of pathogens. Pharma microbiology testing kits support infectious disease diagnosis by enabling accurate and rapid pathogen detection, making them essential for timely clinical decision-making. These kits also enhance laboratory efficiency by ensuring reliable testing and supporting effective treatment strategies and outbreak control. For example, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis cases in England increased to 4,850 in 2023, representing a 10.7% rise from 4,380 cases reported in 2022. As a result, the rising prevalence of infectious diseases is contributing to the expansion of the pharma microbiology testing kits market.
Leading companies operating in the pharma microbiology testing kits market are focusing on adopting innovative technologies, such as artificial intelligence-powered software, to improve efficiency, enhance diagnostic accuracy, and streamline laboratory workflows. Artificial intelligence-powered software in this context refers to advanced algorithms that process and analyze complex diagnostic data to support the detection and identification of pathogens. For example, in May 2023, Becton, Dickinson, and Company, a US-based medical device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BD Kiestra MRSA Imaging Application, which uses artificial intelligence to improve the diagnosis of methicillin-resistant Staphylococcus aureus (MRSA). The application automates the inspection of Petri dishes, a process that is traditionally labor-intensive and time-consuming. It analyzes bacterial growth on BBL CHROMagar MRSA II plates and rapidly identifies specimens with no significant growth, enabling faster processing and quicker release of negative results.
In September 2024, Eurofins Scientific Inc., a Luxembourg-based biopharmaceutical product testing company, acquired Infinity Laboratories Inc. for an undisclosed amount. Through this acquisition, Eurofins seeks to expand its pharmaceutical microbiology testing capabilities, strengthen its footprint in North America, and enhance its portfolio of high-quality analytical and regulatory testing services supporting drug development and manufacturing. Infinity Laboratories Inc. is a US-based pharmaceutical microbiology testing company providing bioburden, sterility, endotoxin, and other microbiological assays for drug development and quality assurance.
Major companies operating in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMérieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation.
North America was the largest region in the pharma microbiology testing kits market in 2025. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharma microbiology testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pharma microbiology testing kits market by increasing costs of imported consumables, reagents, and laboratory equipment, particularly in north america and europe. Consumables and microbial identification equipment segments are most impacted. On the positive side, tariffs are encouraging local reagent manufacturing and strengthening regional supply chains.
The pharma microbiology testing kits market research report is one of a series of new reports that provides pharma microbiology testing kits market statistics, including pharma microbiology testing kits industry global market size, regional shares, competitors with a pharma microbiology testing kits market share, detailed pharma microbiology testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the pharma microbiology testing kits industry. This pharma microbiology testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pharma microbiology testing kits are used to detect contamination and maintain quality standards. They help assess microbial limits in drugs, vaccines, and other biological products.
The primary products in pharma microbiology testing kits include consumables and equipment. Consumables used in pharma microbiology testing kits are designed to identify microbial limits in pharmaceuticals, vaccines, and other biological products. The tests conducted using these kits include endotoxin testing, sterility testing, microbial analysis, environmental monitoring, and others, and they are used by end users such as hospitals and diagnostic centers, contract laboratory service providers, and academic and research institutions.
The pharma microbiology testing kits market consists of sales of rapid test systems, common rapid test kits, rapid tests for salmonella, PCR test, and lateral flow. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $11.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to biopharmaceutical pipeline growth, rapid testing technology adoption, regulatory stringency increase, contract manufacturing expansion, automation in quality control. Major trends in the forecast period include increased sterility testing frequency, rising adoption of rapid microbial detection, expansion of environmental monitoring programs, higher demand for ready-to-use test kits, outsourcing of microbiology testing services.
The growing prevalence of infectious diseases is increasingly supporting the expansion of the pharma microbiology testing kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, which can spread directly or indirectly between individuals. The incidence of infectious diseases continues to rise due to increased global travel, which accelerates the cross-border transmission of pathogens. Pharma microbiology testing kits support infectious disease diagnosis by enabling accurate and rapid pathogen detection, making them essential for timely clinical decision-making. These kits also enhance laboratory efficiency by ensuring reliable testing and supporting effective treatment strategies and outbreak control. For example, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis cases in England increased to 4,850 in 2023, representing a 10.7% rise from 4,380 cases reported in 2022. As a result, the rising prevalence of infectious diseases is contributing to the expansion of the pharma microbiology testing kits market.
Leading companies operating in the pharma microbiology testing kits market are focusing on adopting innovative technologies, such as artificial intelligence-powered software, to improve efficiency, enhance diagnostic accuracy, and streamline laboratory workflows. Artificial intelligence-powered software in this context refers to advanced algorithms that process and analyze complex diagnostic data to support the detection and identification of pathogens. For example, in May 2023, Becton, Dickinson, and Company, a US-based medical device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BD Kiestra MRSA Imaging Application, which uses artificial intelligence to improve the diagnosis of methicillin-resistant Staphylococcus aureus (MRSA). The application automates the inspection of Petri dishes, a process that is traditionally labor-intensive and time-consuming. It analyzes bacterial growth on BBL CHROMagar MRSA II plates and rapidly identifies specimens with no significant growth, enabling faster processing and quicker release of negative results.
In September 2024, Eurofins Scientific Inc., a Luxembourg-based biopharmaceutical product testing company, acquired Infinity Laboratories Inc. for an undisclosed amount. Through this acquisition, Eurofins seeks to expand its pharmaceutical microbiology testing capabilities, strengthen its footprint in North America, and enhance its portfolio of high-quality analytical and regulatory testing services supporting drug development and manufacturing. Infinity Laboratories Inc. is a US-based pharmaceutical microbiology testing company providing bioburden, sterility, endotoxin, and other microbiological assays for drug development and quality assurance.
Major companies operating in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMérieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation.
North America was the largest region in the pharma microbiology testing kits market in 2025. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharma microbiology testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pharma microbiology testing kits market by increasing costs of imported consumables, reagents, and laboratory equipment, particularly in north america and europe. Consumables and microbial identification equipment segments are most impacted. On the positive side, tariffs are encouraging local reagent manufacturing and strengthening regional supply chains.
The pharma microbiology testing kits market research report is one of a series of new reports that provides pharma microbiology testing kits market statistics, including pharma microbiology testing kits industry global market size, regional shares, competitors with a pharma microbiology testing kits market share, detailed pharma microbiology testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the pharma microbiology testing kits industry. This pharma microbiology testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pharma microbiology testing kits are used to detect contamination and maintain quality standards. They help assess microbial limits in drugs, vaccines, and other biological products.
The primary products in pharma microbiology testing kits include consumables and equipment. Consumables used in pharma microbiology testing kits are designed to identify microbial limits in pharmaceuticals, vaccines, and other biological products. The tests conducted using these kits include endotoxin testing, sterility testing, microbial analysis, environmental monitoring, and others, and they are used by end users such as hospitals and diagnostic centers, contract laboratory service providers, and academic and research institutions.
The pharma microbiology testing kits market consists of sales of rapid test systems, common rapid test kits, rapid tests for salmonella, PCR test, and lateral flow. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pharma Microbiology Testing Kits Market Characteristics
3. Pharma Microbiology Testing Kits Market Supply Chain Analysis
4. Global Pharma Microbiology Testing Kits Market Trends and Strategies
5. Pharma Microbiology Testing Kits Market Analysis of End Use Industries
7. Global Pharma Microbiology Testing Kits Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pharma Microbiology Testing Kits Total Addressable Market (TAM) Analysis for the Market
9. Pharma Microbiology Testing Kits Market Segmentation
10. Pharma Microbiology Testing Kits Market Regional and Country Analysis
11. Asia-Pacific Pharma Microbiology Testing Kits Market
12. China Pharma Microbiology Testing Kits Market
13. India Pharma Microbiology Testing Kits Market
14. Japan Pharma Microbiology Testing Kits Market
15. Australia Pharma Microbiology Testing Kits Market
16. Indonesia Pharma Microbiology Testing Kits Market
17. South Korea Pharma Microbiology Testing Kits Market
18. Taiwan Pharma Microbiology Testing Kits Market
19. South East Asia Pharma Microbiology Testing Kits Market
20. Western Europe Pharma Microbiology Testing Kits Market
21. UK Pharma Microbiology Testing Kits Market
22. Germany Pharma Microbiology Testing Kits Market
23. France Pharma Microbiology Testing Kits Market
24. Italy Pharma Microbiology Testing Kits Market
25. Spain Pharma Microbiology Testing Kits Market
26. Eastern Europe Pharma Microbiology Testing Kits Market
27. Russia Pharma Microbiology Testing Kits Market
28. North America Pharma Microbiology Testing Kits Market
29. USA Pharma Microbiology Testing Kits Market
30. Canada Pharma Microbiology Testing Kits Market
31. South America Pharma Microbiology Testing Kits Market
32. Brazil Pharma Microbiology Testing Kits Market
33. Middle East Pharma Microbiology Testing Kits Market
34. Africa Pharma Microbiology Testing Kits Market
36. Pharma Microbiology Testing Kits Market Competitive Landscape and Company Profiles
37. Pharma Microbiology Testing Kits Market Other Major and Innovative Companies
40. Pharma Microbiology Testing Kits Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pharma Microbiology Testing Kits Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pharma microbiology testing kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pharma microbiology testing kits? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharma microbiology testing kits market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Consumables; Equipment2) By Test: Endotoxin Testing; Sterility Testing; Microbial Examination; Environmental Monitoring; Other Tests
3) By End User: Hospitals And Diagnostic Centers; Custom Lab Service Providers; Academic And Research Institutes
Subsegments:
1) By Consumables: Media and Reagents; Test Kits; Sample Collection Containers2) By Equipment: Incubators; Autoclaves; Microbial Identification Systems
Companies Mentioned: F. Hoffmann-La Roche AG; Becton Dickinson and Company; Abbott Laboratories; ThermoFisher Scientific; SGS SA; Toxikon Corp.; Pace Analytical Services; Boston Analytics; Charles River Laboratories International; Nelson Laboratories; Siemens healthcare AG; Hologic Inc.; Neogen Corporation; Shimadzu Corporation; Merck KGaA; Agilent TechnologiesInc.; QIAGEN N.V.; Bruker Corporation; bioMérieux SA; Lucideon; Lonza Group AG; MilliporeSigma; Hardy Diagnostics; Sartorius AG; 3M Company; Waters Corporation; PerkinElmer Inc.; Luminex Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pharma Microbiology Testing Kits market report include:- F. Hoffmann-La Roche AG
- Becton Dickinson and Company
- Abbott Laboratories
- ThermoFisher Scientific
- SGS SA
- Toxikon Corp.
- Pace Analytical Services
- Boston Analytics
- Charles River Laboratories International
- Nelson Laboratories
- Siemens healthcare AG
- Hologic Inc.
- Neogen Corporation
- Shimadzu Corporation
- Merck KGaA
- Agilent TechnologiesInc.
- QIAGEN N.V.
- Bruker Corporation
- bioMérieux SA
- Lucideon
- Lonza Group AG
- MilliporeSigma
- Hardy Diagnostics
- Sartorius AG
- 3M Company
- Waters Corporation
- PerkinElmer Inc.
- Luminex Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.94 Billion |
| Forecasted Market Value ( USD | $ 11.98 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
